Radiation Retinopathy Clinical Trial
Official title:
A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation in Subjects With Radiation Retinopathy (RRR Study).
The purpose of this study is to assess the tolerability and efficacy of ranibizumab treatment administered in subjects with radiation retinopathy
RRR is a phase II, randomized, multicenter, clinical study to assess the tolerability and efficacy of ranibizumab treatment administered in subjects with radiation retinopathy. Subjects will be randomized into one of 3 arms; intravitreal (IVT) monthly vs. ranibizumab treatment administered IVT monthly combined with peripheral targeted photocoagulation vs. ranibizumab treatment administered IVT for three months followed by as needed treatment of ranibizumab combined with peripheral targeted photocoagulation over 48 weeks. From week 52 to week 101, all 3 treatment arms will employ a treat and extend protocol for IVT ranibizumab treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04120311 -
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
| Completed |
NCT00750399 -
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
|
Phase 1 | |
| Recruiting |
NCT05844982 -
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
|
Phase 3 | |
| Completed |
NCT01579760 -
Intravitreal Aflibercept Injection for Radiation Retinopathy
|
Phase 1 | |
| Completed |
NCT01334879 -
High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
|
Phase 1 | |
| Active, not recruiting |
NCT04120636 -
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
| Active, not recruiting |
NCT03085784 -
Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
|
Phase 2 | |
| Withdrawn |
NCT03238157 -
Steroids for Early Treatment of Radiation Retinopathy
|
Phase 2/Phase 3 | |
| Terminated |
NCT01471054 -
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
|
Phase 2 | |
| Active, not recruiting |
NCT00540930 -
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
|
Phase 4 |